Showing results (2581-2590 of 3,013) with videos related to

Sort By:
Pageof 302
Journal of Inherited Metabolic Disease|April 2, 2020
Responsiveness of sphingosine phosphate lyase insufficiency syndrome to vitamin B6 cofactor supplementationPiming Zhao, Isaac D Liu, Jeffrey B Hodgin, et al.
Open Forum Infectious Diseases|October 16, 2024
Outcomes of Haploidentical Stem Cell Transplant Recipients With HHV-6B ReactivationGuy Handley, Amanda Yepes, Eva Eliassen, et al.
BMC Nephrology|June 2, 2025
Using vascular biomarkers to assess heart failure event risk in hospitalized patients with and without AKIAudrey A Shi, Anna Simone Andrawis, Aditya Biswas, et al.
Nature Reviews. Nephrology|February 28, 2017
Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 WorkgroupLakhmir S Chawla, Rinaldo Bellomo, Azra Bihorac, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|September 9, 2020
Differential effects of the cystic fibrosis lung inflammatory environment on mesenchymal stromal cellsSoraia C Abreu, Thomas H Hampton, Evan Hoffman, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 15, 2022
Plasma Soluble Tumor Necrosis Factor Receptor Concentrations and Clinical Events After Hospitalization: Findings From the ASSESS-AKI and ARID StudiesSteven G Coca, George Vasquez-Rios, Sherry G Mansour, et al.
Transplantation and Cellular Therapy|September 21, 2024
Prospective Assessment of Quality of Life and Patient-Reported Toxicities Over the First Year After Chimeric Antigen Receptor T-Cell TherapyAasha I Hoogland, Anna Barata, Xiaoyin Li, et al.
The Lancet. Respiratory Medicine|August 26, 2023
Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trialsPratik Sinha, V Eric Kerchberger, Andrew Willmore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 27, 2025
9MW2821, a next-generation Nectin-4 targeting antibody-drug conjugate, in patients with advanced solid tumors: a first-in-human, open label, multicenter, phase Ⅰ/Ⅱ studyJ Zhang, R Liu, S Wang, et al.
Pageof 302